©The Author(s) 2026.
World J Gastroenterol. Jan 7, 2026; 32(1): 114558
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.114558
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.114558
Table 2 Clinical trials of Huangqin decoction in ulcerative colitis treatment
| Treatments | Dosage of Huangqin | Number of patients in control/ | Results (overall response rate), % | Adverse events/number of patients | Ref. | ||
| Control groups | Intervention group | ||||||
| Huangqin decoction | Control group: Oral administration of sulfasalazine 3 g/day. Intervention group: Oral Huangqin decoction (huangqin 20 g, baishao 15 g, gancao 15 g, dazao 30 g). Treatment time: 2 months | 20 g | 32/32 | 78.13 | 81.25 | Not reported | [123] |
| Control group: Oral sulfasalazine 3 g/day. Intervention group: Oral Huangqin decoction (huangqin 20 g, baishao 15 g, dazao 30 g, gancao 15 g). Treatment time: 2 months | 20 g | 32/31 | 87.50 | 90.32 | Not reported | [124] | |
| Control group: Oral sulfasalazine 9 tablets/day (dose reduced to 4.5 tablets/day after 2 weeks). Intervention group: Oral modified Huangqin decoction (huangqin 8 g, baishao 6 g, zhigancao 4 g, dazao 8 pieces, adjusted according to symptoms). Treatment time: 1 month | 8 g | 68/68 | 41.18 | 97.06 | Control group: Leukopenia/3, headache and nausea/3, arthritis/1. Intervention group: 0 | [125] | |
| Control group: Oral sulfasalazine 4 g/d. Intervention group: Oral Huangqin decoction granules (huangqin 20 g, baishao 10 g, gancao 6 g, dazao 10 g). Treatment time: 2 months | 20 g | 68/68 | 70 | 86.7 | Not reported | [126] | |
| Control group: Antibiotics, corticosteroids, immunosuppressants, etc. Intervention group: Oral Huangqin decoction (huangqin 15 g, huanglian 10 g, zhizi 10 g, huangbo 10 g). Treatment time: 30 days | 15 g | 50/50 | 68.00 | 90.00 | Not reported | [127] | |
| Group 1: Oral administration of 4 g/day sulfasalazine + 9 tablets/day berberine. Group 2: Retention enema with Chinese patent medicine named Jiechangning. Group 3: Oral modified Huangqin decoction (huangqin 12 g, shaoyao 9 g, zhigancao 6 g, dazao 10 pieces, adjusted according to symptoms). Group 4: Groups 2 plus 3 regimens. Treatment time: 2 months | 12 g | 20/20/20/20 | Group 1: 65. Group 2: 75. Group 4: 95 | 70 | Not reported | [128] | |
| Huangqin decoction plus western medicine | Control group: Oral mesalazine 4 g/day + peifeikang capsules 1.26 g/day. Intervention group: Oral Peifeikang capsules 1.26 g/day + Huangqin decoction (huangqin 20 g, baishao 15 g, gancao 15 g, dazao 15 g, adjusted according to symptoms). Treatment time: 2 months | 20 g | 35/35 | 65.7 | 85.7 | Control group: Mild nausea and vomiting/2. Intervention group: 0 | [129] |
| Control group: Oral sulfasalazine 4 g/day. Intervention group: Control group treatment + Huangqin decoction granules orally (dazao 10 g, huangqin 2 0 g, gancao 6 g, baishao 10 g). Treatment time: Not stated | 20 g | 56/56 | 69.6 | 92.9 | Control group: Arthritis/1, leukopenia/3, headache and nausea/3. Intervention group: 0 | [130] | |
| Control group: Oral mesalazine enteric-coated tablets 3 g/day. Intervention group: Control group treatment + Huangqin decoction granules orally (huangqin 20 g, baishao 10 g, gancao 6 g, dazao 10 g). Treatment time: 2 months | 20 g | 34/34 | 76.5 | 91.2 | Not reported | [131] | |
| Control group: Oral administration of 9 g/day sulfasalazine enteric-coated tablets. Intervention group: Control group treatment + Huangqin decoction orally (huangqin 30 g, baishao 20 g, gancao 20 g, dazao 20 g). Treatment time: 1 month | 30 g | 37/37 | 60.53 | 83.78 | Control group: Nausea/4, fatigue/3, dizziness/1. Intervention group: Nausea/1, fatigue/1 | [11] | |
| Control group: Oral mesalazine granules 3 g/day. Intervention group: Control group treatment + Huangqin decoction granules orally (huangqin 20 g, baishao 10 g, gancao 6 g, dazao 10 g). Treatment time: 2 months | 20 g | 63/63 | 80.95 | 96.83 | Not reported | [132] | |
| Control group: Oral mesalazine 3 g/day. Intervention group: Control group treatment + Huangqin decoction orally (huangqin 25 g, baishao 20 g, dazao 30 g, gancao 12 g, adjusted according to symptoms). Treatment time: 3 months | 25 g | 39/39 | 58.97 | 82.05 | Control group: Nausea and vomiting/2, fatigue/1, dizziness/3, mild skin itching/2. Intervention group: Nausea and vomiting/1, dizziness/1 | [133] | |
| Control group: Mesalazine sustained-release granules 4 g/day orally. Intervention group: Control group treatment plus modified Huangqin decoction administered orally (huangqin 20 g, baishao 15 g, gancao 15 g, dazao 15 g, adjusted according to symptoms). Treatment time: 2 months | 20 g | 41/41 | 68.29 | 90.24 | Not reported | [134] | |
| Control group: Oral mesalazine granules 4 g/day. Intervention group: Control group treatment + modified Huangqin decoction orally (huangqin 20 g, baishao 15 g, gancao 15 g, dazao 15 g, adjusted according to symptoms). Treatment time: 2 months | 20 g | 58/58 | 77.59 | 91.38 | Not reported | [135] | |
| Control group: Oral mesalazine enteric-coated tablets 1.5 g/day. Intervention group: Control group treatment + Huangqin decoction enema (huangqin 9 g, shaoyao 6 g, dazao 12 g, zhigancao 6 g). Treatment time: 30 days | 9 g | 40/40 | 72.50 | 95.00 | Control group: Nausea and vomiting/2, dizziness/1, rash/2. Intervention group: Dizziness/1, rash/1 | [136] | |
| Control group: Oral mesalazine enteric-coated tablets 4 g/day. Intervention group: Control group treatment + Huangqin decoction orally (huangqin 12 g, baishao 15 g, baizhu 15 g, yiyiren 15 g, mudanpi 10 g, diyu 10 g, qinpi 10 g, baiji 6 g, zhigancao 6 g). Treatment time: 2 months | 12 g | 40/40 | 75.00 | 92.50 | Not reported | [137] | |
| Control group: Bifidobacterium quadruple live bacteria tablets 4.5 g + mesalazine enteric-coated tablets 4 g/day orally. Intervention group: Control group treatment + Huangqin decoction enema (dazao 12 pieces, huangqin 9 g, zhigancao 6 g, shaoyao 6 g). Treatment time: 1 month | 9 g | 47/48 | 76.60 | 91.67 | Control group: Nausea/1, vomiting/1, abdominal distension/1. Intervention group: Nausea/2, abdominal distension/2 | [138] | |
- Citation: Ding Y, Wang CY, Pan YT, Wang YJ, Zhao AG, Wen HZ. Scutellaria baicalensis Georgi as a potential therapeutic drug intervention in ulcerative colitis: Mechanisms of action and clinical trials. World J Gastroenterol 2026; 32(1): 114558
- URL: https://www.wjgnet.com/1007-9327/full/v32/i1/114558.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i1.114558